| Title |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2013
|
| DOI | 10.1002/14651858.cd009764.pub2 |
| Pubmed ID | |
| Authors |
Samantha C Herath, Phillippa Poole |
| Abstract |
There has been renewal of interest in the use of prophylactic antibiotics to reduce the frequency of exacerbations and improve quality of life in chronic obstructive pulmonary disease (COPD). |
X Demographics
The data shown below were collected from the profiles of 70 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 12 | 17% |
| Spain | 6 | 9% |
| United States | 4 | 6% |
| Chile | 3 | 4% |
| Ecuador | 2 | 3% |
| Canada | 2 | 3% |
| Mexico | 1 | 1% |
| Turkey | 1 | 1% |
| Kuwait | 1 | 1% |
| Other | 5 | 7% |
| Unknown | 33 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 47 | 67% |
| Practitioners (doctors, other healthcare professionals) | 17 | 24% |
| Scientists | 4 | 6% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 208 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 205 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 34 | 16% |
| Researcher | 30 | 14% |
| Student > Ph. D. Student | 24 | 12% |
| Student > Postgraduate | 17 | 8% |
| Other | 17 | 8% |
| Other | 41 | 20% |
| Unknown | 45 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 89 | 43% |
| Nursing and Health Professions | 19 | 9% |
| Psychology | 14 | 7% |
| Agricultural and Biological Sciences | 7 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 3% |
| Other | 22 | 11% |
| Unknown | 50 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 58. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 February 2019.
All research outputs
#743,621
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#1,386
of 13,156 outputs
Outputs of similar age
#7,501
of 321,177 outputs
Outputs of similar age from Cochrane database of systematic reviews
#27
of 239 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 321,177 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 239 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.